510(k) K182984— MaxiTears Contacts PF

Substantially Equivalent

Omnivision AG

Clearance details

Applicant: Omnivision AG
Product code: Code MRC
Advisory panel: Ophthalmic
Date received: 2018-10-29
Decision date: 2019-07-24
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Neuhausen Am Rheinfall, CH

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.